Factors tested in migration on PDL | Concentration |
---|---|
Bone morphogenic protein-7 | 50 ng/ml |
Ciliary neurotrophic factor | 50 ng/ml |
Brain-derived neurotrophic factor | 100 ng/ml |
Neurotrophin-4 | 10, 100, 500 ng/ml |
Epidermal growth factor | 10, 50 ng/ml |
Endothelial cell growth factor | 20, 100 ng/ml |
Keratinocyte growth factor | 10, 100 ng/ml |
Glial-derived neurotrophic factor | 20 ng/ml |
Granulocyte colony stimulating factor | 10 U/ml |
Granulocyte-macrophage colony stimulating factor | 10 U/ml |
Hepatocyte growth factor/scatter factor | 100 ng/ml |
Leukocyte inhibitory factor | 10 ng/ml |
Insulin-like growth factor-1 | 5, 50, 100 ng/ml |
Platelet-derived growth factor B/B | 5, 10, 20, 100, 200 ng/ml |
Retinoic acid | 100 nm |
Stem cell factor | 50 ng/ml |
Transforming growth factor-α | 5, 50 ng/ml |
Transforming growth factor-β1 | 10 ng/ml |
Tumor necrosis factor-α | 5 ng/ml |
Leupeptin | 100 mm |
High potassium (KCl) | 25 mm |
Tetraethylammonium | 10 mm |
2-Amino-5-phosphono-valerate | 100 mm |
Tetrodotoxin | 1 mm |
ω-Conotoxin | 1 μm, 1 mm |
Forskolin | 5 μm |
Pertussis toxin | 100 ng/ml |
All treatments were tested for changes in migration in serum-containing and serum-free medium (1 and 2 DIV). None of the treatments led to significant changes in migration.